VIKING GLOBAL INVESTORS LP - Q3 2022 holdings

$21.7 Billion is the total value of VIKING GLOBAL INVESTORS LP's 88 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 34.1% .

 Value Shares↓ Weighting
CB SellCHUBB LIMITED$653,539,000
-11.9%
3,593,242
-4.8%
3.02%
-11.1%
MA SellMASTERCARD INCORPORATEDcl a$503,448,000
-30.7%
1,770,583
-23.1%
2.32%
-30.0%
TMUS SellT-MOBILE US INC$446,062,000
-63.8%
3,324,606
-63.7%
2.06%
-63.5%
RPRX SellROYALTY PHARMA PLC$437,222,000
-15.9%
10,881,594
-12.0%
2.02%
-15.1%
UBER SellUBER TECHNOLOGIES INC$434,497,000
+28.1%
16,396,107
-1.1%
2.01%
+29.3%
PH SellPARKER-HANNIFIN CORP$430,210,000
-43.1%
1,775,453
-42.2%
1.99%
-42.5%
FTV SellFORTIVE CORP$354,242,000
-44.8%
6,076,200
-48.5%
1.64%
-44.3%
IFF SellINTERNATIONAL FLAVORS&FRAGRA$338,499,000
-44.5%
3,726,736
-27.2%
1.56%
-44.0%
TMO SellTHERMO FISHER SCIENTIFIC INC$301,036,000
-35.8%
593,537
-31.2%
1.39%
-35.1%
SQ SellBLOCK INCcl a$292,055,000
-15.2%
5,311,049
-5.2%
1.35%
-14.4%
ACHC SellACADIA HEALTHCARE COMPANY IN$231,329,000
-1.7%
2,958,932
-14.9%
1.07%
-0.7%
KRTX SellKARUNA THERAPEUTICS INC$228,105,000
+61.1%
1,014,116
-9.4%
1.05%
+62.5%
GH SellGUARDANT HEALTH INC$206,471,000
+14.3%
3,835,610
-14.4%
0.95%
+15.4%
SellAMYLYX PHARMACEUTICALS INC$162,441,000
+17.6%
5,770,536
-19.5%
0.75%
+18.7%
MMC SellMARSH & MCLENNAN COS INC$150,320,000
-65.8%
1,006,898
-64.4%
0.69%
-65.5%
MOH SellMOLINA HEALTHCARE INC$134,136,000
+1.0%
406,671
-14.4%
0.62%
+1.8%
CTLT SellCATALENT INC$121,113,000
-42.4%
1,673,755
-14.7%
0.56%
-41.9%
NTLA SellINTELLIA THERAPEUTICS INC$105,712,000
-8.3%
1,889,067
-15.2%
0.49%
-7.6%
ZLAB SellZAI LAB LTDadr$89,427,000
-21.9%
2,614,817
-20.8%
0.41%
-21.0%
PGR SellPROGRESSIVE CORP$85,596,000
-18.4%
736,561
-18.3%
0.40%
-17.7%
BEKE SellKE HLDGS INCsponsored ads$68,240,000
-63.5%
3,895,000
-62.6%
0.32%
-63.2%
AVTR SellAVANTOR INC$56,814,000
-70.4%
2,898,662
-53.0%
0.26%
-70.2%
SWAV SellSHOCKWAVE MED INC$43,748,000
-19.4%
157,327
-44.6%
0.20%
-18.5%
GLBE SellGLOBAL E ONLINE LTD$42,163,000
-31.3%
1,575,580
-48.3%
0.20%
-30.6%
OHPAU SellORION ACQUISITION CORPunit 02/19/2026$35,821,000
-1.4%
3,629,247
-2.0%
0.16%
-0.6%
DAWN SellDAY ONE BIOPHARMACEUTICALS I$31,218,000
-6.1%
1,558,563
-16.1%
0.14%
-5.3%
LVS SellLAS VEGAS SANDS CORP$14,241,000
-56.1%
379,551
-60.7%
0.07%
-55.4%
ExitNUVALENT INC$0-1,110,170
-100.0%
-0.07%
CAR ExitAVIS BUDGET GROUP$0-278,673
-100.0%
-0.19%
ExitPROCEPT BIOROBOTICS CORP$0-1,545,000
-100.0%
-0.23%
ZNTL ExitZENTALIS PHARMACEUTICALS INC$0-2,026,656
-100.0%
-0.26%
CLDX ExitCELLDEX THERAPEUTICS INC NEW$0-2,337,854
-100.0%
-0.29%
COUP ExitCOUPA SOFTWARE INC$0-1,414,833
-100.0%
-0.37%
WDAY ExitWORKDAY INCcl a$0-1,068,804
-100.0%
-0.68%
BKNG ExitBOOKING HOLDINGS INC$0-89,251
-100.0%
-0.71%
DIS ExitDISNEY WALT CO$0-1,741,500
-100.0%
-0.75%
AON ExitAON PLC$0-704,639
-100.0%
-0.87%
BA ExitBOEING CO$0-1,391,238
-100.0%
-0.87%
LRCX ExitLAM RESEARCH CORP$0-694,026
-100.0%
-1.35%
AIG ExitAMERICAN INTL GROUP INC$0-10,108,715
-100.0%
-2.36%
CNC ExitCENTENE CORP DEL$0-8,293,867
-100.0%
-3.21%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VISA INC36Q3 20237.0%
AMAZON COM INC34Q3 202310.6%
META PLATFORMS INC34Q3 202310.4%
MICROSOFT CORP30Q3 20239.1%
THERMO FISHER SCIENTIFIC INC29Q3 20235.4%
NETFLIX INC26Q2 20236.0%
MASTERCARD INCORPORATED25Q3 20233.9%
ELEVANCE HEALTH INC24Q2 202310.2%
ALPHABET INC22Q2 20219.3%
UNITEDHEALTH GROUP INC22Q3 20235.3%

View VIKING GLOBAL INVESTORS LP's complete holdings history.

Latest significant ownerships (13-D/G)
VIKING GLOBAL INVESTORS LP Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Celldex Therapeutics, Inc.Sold outFebruary 14, 202300.0%
Coupa Software IncSold outFebruary 14, 202300.0%
FIGS, Inc.Sold outFebruary 14, 202300.0%
Guardant Health, Inc.February 14, 20234,107,6444.0%
Orion Acquisition Corp.Sold outFebruary 14, 202300.0%
PROCEPT BioRobotics CorpSold outFebruary 14, 202300.0%
Frazier Lifesciences Acquisition CorpSold outNovember 25, 202200.0%
Cazoo Group LtdNovember 10, 202260,000,0007.3%
AbCellera Biologics Inc.Sold outFebruary 14, 202200.0%
Athira Pharma, Inc.Sold outFebruary 14, 202200.0%

View VIKING GLOBAL INVESTORS LP's complete significant-ownership history.

Latest filings
TypeFiled
32024-03-20
SC 13G/A2024-03-20
42024-03-07
42024-03-07
42024-03-01
42024-03-01
SC 13G/A2024-03-01
42024-02-28
42024-02-28
SC 13G/A2024-02-28

View VIKING GLOBAL INVESTORS LP's complete filings history.

Compare quarters

Export VIKING GLOBAL INVESTORS LP's holdings